Verhofstede C - Search Results

1

Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.

Messiaen P, Verhofstede C, Vandenbroucke I, Dinakis S, Van Eygen V, Thys K, Winters B, Aerssens J, Vogelaers D, Stuyver LJ, Vandekerckhove L. Messiaen P, et al. Among authors: verhofstede c. Virology. 2012 Apr 25;426(1):7-11. doi: 10.1016/j.virol.2012.01.002. Epub 2012 Feb 4. Virology. 2012. PMID: 22305619 Free article.

2

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.

Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Verhofstede C, Rimland D, Schinazi RF, Rossau R. Stuyver L, et al. Among authors: verhofstede c. Antimicrob Agents Chemother. 1997 Feb;41(2):284-91. doi: 10.1128/AAC.41.2.284. Antimicrob Agents Chemother. 1997. PMID: 9021181 Free PMC article.

3

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.

Verhofstede C, Wanzeele FV, Van Der Gucht B, De Cabooter N, Plum J. Verhofstede C, et al. AIDS. 1999 Dec 24;13(18):2541-6. doi: 10.1097/00002030-199912240-00007. AIDS. 1999. PMID: 10630523 Clinical Trial.

4

Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.

Van Vaerenbergh K, Van Laethem K, Van Wijngaerden E, Schmit JC, Schneider F, Ruiz L, Clotet B, Verhofstede C, Van Wanzeele F, Muyldermans G, Simons P, Stuyver L, Hermans P, Evans C, De Clercq E, Desmyter J, Vandamme AM. Van Vaerenbergh K, et al. Among authors: verhofstede c. AIDS Res Hum Retroviruses. 2000 Apr 10;16(6):529-37. doi: 10.1089/088922200308945. AIDS Res Hum Retroviruses. 2000. PMID: 10777143

5

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.

Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM. Van Vaerenbergh K, et al. Among authors: verhofstede c. Antivir Ther. 2001 Mar;6(1):63-70. Antivir Ther. 2001. PMID: 11417763

6

Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A.

Verhofstede C, Demecheleer E, De Cabooter N, Gaillard P, Mwanyumba F, Claeys P, Chohan V, Mandaliya K, Temmerman M, Plum J. Verhofstede C, et al. J Virol. 2003 Mar;77(5):3050-7. doi: 10.1128/jvi.77.5.3050-3057.2003. J Virol. 2003. PMID: 12584330 Free PMC article.

7

Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.

Verhofstede C, Noë A, Demecheleer E, De Cabooter N, Van Wanzeele F, Van Der Gucht B, Vogelaers D, Plum J. Verhofstede C, et al. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):473-83. doi: 10.1097/00126334-200404150-00005. J Acquir Immune Defic Syndr. 2004. PMID: 15021312

8

The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance.

Noë A, Plum J, Verhofstede C. Noë A, et al. Among authors: verhofstede c. J Antimicrob Chemother. 2005 Apr;55(4):410-2. doi: 10.1093/jac/dki038. Epub 2005 Feb 22. J Antimicrob Chemother. 2005. PMID: 15728140 Review.

9

A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.

Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, Mandaliya K, Plum J, Verhofstede C. Steegen K, et al. Among authors: verhofstede c. J Virol Methods. 2006 May;133(2):137-45. doi: 10.1016/j.jviromet.2005.11.004. Epub 2005 Dec 20. J Virol Methods. 2006. PMID: 16375980

10

Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.

Verhofstede C, Van Wanzeele F, Van Der Gucht B, Pelgrom J, Vandekerckhove L, Plum J, Vogelaers D. Verhofstede C, et al. J Med Virol. 2007 Sep;79(9):1254-60. doi: 10.1002/jmv.20950. J Med Virol. 2007. PMID: 17607772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters